eureKARE participates in DNA Script's $200 Million Series C Financing

eureKARE participates in DNA Script's $200 Million Series C Financing Fundraise will accelerate commercial launch of revolutionary enzymatic DNA printing technology Luxembourg and Paris

Related Keywords

Luxembourg ,Paris ,France General ,France ,Belgium ,Amber Fennell ,Genevieve Wilson ,Kostenloser Wertpapierhandel ,Alexandre Mouradian ,Baillie Gifford ,Sukaina Virji ,Marina Shapochnik ,Linkedin ,T Rowe Price Associates ,Consilium Strategic Communications ,Price Associates ,Healthcor Management ,Irving Investors ,Coatue Management ,Catalio Capital Management ,Fidelity Management ,Columbia Threadneedle Investments ,Casdin Capital ,Chief Executive Officer ,Omne Possibile ,Coave Therapeutics ,Head Investor ,Eurekare ,Participates ,Script ,Billion ,Series ,Financing ,